ALPH — AlphaHelix Molecular Diagnostics AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK21.56m
- SEK19.03m
- SEK26.67m
Annual cashflow statement for AlphaHelix Molecular Diagnostics AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS | ARS |
| Standards: | — | SAS | SAS | — | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.973 | 1.52 | 5.21 | -2.41 | -9.69 |
| Depreciation | |||||
| Non-Cash Items | 0.221 | 0.577 | 0.492 | 0.902 | 1.88 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.563 | -0.468 | -5.34 | 2.2 | 0.177 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.069 | 1.84 | 1.63 | 2.87 | -5.45 |
| Capital Expenditures | — | — | — | -0.288 | -0.043 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.046 | 0.3 | -4.34 | -0.3 | 0.771 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.046 | 0.3 | -4.34 | -0.588 | 0.728 |
| Financing Cash Flow Items | — | — | -0.645 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.007 | -1.13 | 7.16 | -0.3 | 0.507 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.122 | 1.01 | 4.44 | 1.98 | -4.21 |